Inositol supplementation in pregnancies at risk of apparently folate-resistant NTDs.
Cavalli
Pietro
P
Tedoldi
Sara
S
Riboli
Barbara
B
D045103:5,10-Methylenetetrahydrofolate Reductase (FADH2) / Q000235:genetics; D000328:Adult; D003541:Cystathionine beta-Synthase / Q000235:genetics; D004351:Drug Resistance; D005260:Female; D005287:Ferredoxin-NADP Reductase / Q000235:genetics; D005492:Folic Acid / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D007234:Infant, Premature; D007294:Inositol / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D009436:Neural Tube Defects / Q000209:etiology / Q000517:prevention & control*; D011110:Polymorphism, Genetic; D011247:Pregnancy; D011256:Pregnancy Outcome; D012307:Risk Factors
D007294:Inositol; D005492:Folic Acid; C111241:methionine synthase reductase; D005287:Ferredoxin-NADP Reductase; D045103:5,10-Methylenetetrahydrofolate Reductase (FADH2); D003541:Cystathionine beta-Synthase